[Form 4] Corebridge Financial, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Elizabeth B. Cropper, EVP & Chief Human Resources Officer and director of Corebridge Financial, Inc. (CRBG), was granted 9,296 time‑vested restricted stock units (RSUs) on 09/19/2025. The RSUs carry a $0 purchase price and were granted under the Company’s 2022 Omnibus Incentive Plan. The award is a special retention grant that cliffs vests 100% on 09/30/2027, subject to continued employment through the vesting date. Following the grant, the reporting person beneficially owns 52,289 shares/units. The filing was submitted on 09/23/2025 and is signed by an attorney‑in‑fact.
Positive
- 9,296 RSUs granted as a retention award, explicitly disclosed
- 100% cliff vesting on 09/30/2027 provides a clear retention timeline
- Grant made under the 2022 Omnibus Incentive Plan and noted as exempt under Rule 16b‑3
- Post‑grant beneficial ownership disclosed: 52,289 shares/units
Negative
- None.
Insights
TL;DR: A time‑vested retention RSU award was granted to a senior officer to support retention through 2027.
The grant of 9,296 RSUs to an executive and director aligns with common retention practices for senior management. The cliff vesting to a single date in 2027 is straightforward and conditions vesting solely on continued employment, per the disclosure. The award is reported as exempt under Rule 16b‑3, indicating compliance with insider transaction rules. The filing provides clear disclosure of title, amount, vesting date, and post‑grant beneficial ownership, enabling investors to track insider incentives without ambiguity.
TL;DR: The award is a retention‑focused equity grant with full cliff vesting in two years, increasing insider holdings modestly.
The RSU grant of 9,296 units at $0 increases the reporting person’s beneficial position to 52,289 shares/units, reflecting an incremental equity stake rather than a cash transaction. Cliff vesting on a single future date provides a clear retention horizon through late 2027. The disclosure cites the 2022 Omnibus Incentive Plan as the grant vehicle and notes Rule 16b‑3 exemption, which is standard for such grants. The filing lacks additional compensation metrics (grant‑date fair value or percent of outstanding equity), so analysis of size relative to total dilution is not possible from this form alone.